Empower your cancer care with advanced screening, diagnosis, therapy, and monitoring solutions.

Screening

Non-Invasive Cancer Screening for People Without Symptoms

For early cancer detection, think of

EasyCheck360®

Why is early cancer screening important for cancer management?

Early cancer screening is crucial because it increases the chances of detecting cancer at an initial stage when it is more likely to respond to treatment, improving survival rates, and enabling potentially curative options. Early-stage detection often allows for less aggressive treatments, reduces healthcare costs, and enhances the quality of life of patients by catching the disease before it progresses to advanced, harder-to-treat stages.

How can Easycheck360® help in early cancer screening?

EasyCheck360® is a non-invasive blood test designed to detect cancer early by identifying Circulating Tumour Cells (CTCs). These cells are only found in individuals with cancer and are not present in people with non-cancerous conditions, making this test highly accurate. EasyCheck360® can detect CTCs in almost all types of cancer, including early stages (Stage 0, I, and II), in both men and women.

By providing reliable results, this test helps your doctor make timely and informed decisions about your health, giving you the best chance for early diagnosis and potentially curative treatment.

KNOW MORE

Diagnosis

Risk-free, blood-based biopsy

Usual invasive tissue biopsy for cancer diagnosis can be cumbersome, carries risk for a patient, and sometimes is inaccurate too.

Trublood™ offers a risk-free, accurate, and cost-effective alternative to traditional biopsies for detecting solid and brain tumours. It is a safe method that remains effective even when primary or metastatic cancers are undetectable by conventional means, providing crucial diagnostic insights without invasive procedures.

Trublood™ can avoid pain and anxiety related to traditional biopsies with a non-invasive solution to detect colorectal cancer and cancers of the CNS, lung, breast, pancreas, and prostate.

Key Benefits of Trublood ™

  • Totally non-invasive and is ultimately less expensive
  • No hospitalisation
  • No pain, no stitches, and no scars
  • No risk of injury to any organ
  • Provides 'real-time' data and covers all active sites
  • Can be performed as often as necessary
  • Viable even if primary/metastasis is undetectable.
KNOW MORE
blood-based-cancer-biopsy

Therapy Guidance

Get personalised treatment plans

designed just for you, to help you stay strong in your cancer fight.

  • When Dealing with Advanced Cancer, Think of

    Exacta™ | Pinaka™ | Celldx™ | Chemoscale™ | Cancertrack™ | Target-MRD™

    Cancer is a genetic disease. Every human being is different and unique, so is his/her cancer. However, the conventional 'standard of care' approach is based on population studies, which disregard the unique genetic landscape and complex metabolic dynamics of the tumour. As a result, the patients are at risk of failed therapies or aggressive relapse. It is, thus, imperative that the genetic architecture of the tumour is studied comprehensively before deciding the treatment plan, which has to be personalised to the individual patient and his/her disease.

    Why Choose Datar's Treatment Solutions?

    Datar offers advanced and comprehensive tumour profiling tests that analyse cellular and genetic data to provide personalised and actionable treatment recommendations. These tests ensure that every treatment plan is tailored to your specific cancer profile.

  • Exacta™

    Exacta™ is a comprehensive, in-depth, integrative, cellular, and molecular tumour analysis that parses millions of data points to present actionable vulnerabilities of the tumour for effective treatment strategies.

    KNOW MORE

  • Pinaka™

    Pinaka™ is a non-invasive blood test that detects Circulating Tumour Cells (CTCs) from your bloodstream, providing crucial insights to guide cancer treatment. Using advanced techniques like immunocytochemistry (ICC) and FISH, Pinaka™ analyses key biomarkers to match you with the most effective therapies. With just a quick blood draw, this test offers accurate and reliable information comparable to traditional tumour tissue testing, making cancer care safer and more personalised.

    KNOW MORE

  • Celldx™

    Celldx™provides deep genetic analysis of a tumour, offering insights into key alterations that can guide personalised treatment to 'target' only cancer cells in your body without affecting the normal cells or to stimulate or suppress your 'immune system' to help your body fight cancer.

    KNOW MORE

  • Chemoscale™

    Chemoscale™ provides blood-based analysis of tumour cells to guide you on which chemotherapy drug will work for you and to predict resistance to any chemotherapy drug.

    KNOW MORE
monitoring-DNA

Monitoring

Keep a close watch on your progress and catch any changes early with regular monitoring.

 

 

 

 

 

For a safe and non-invasive
cancer diagnosis, think

Cancertrack™

Cancertrack™ offers a non-invasive and blood-based test that detects cancer biomarkers with high precision, allowing frequent monitoring of disease progression or recurrence. It eliminates the need for radiation, hospitalisation, anaesthesia, or painful biopsies, providing a safer and more efficient way to track how your cancer responds to therapy and monitor further progression.
KNOW MORE

cancer-screening
cancer-screening

For even deeper insights, Target-MRD™ is an advanced blood test designed to detect even the tiniest traces of cancer, known as Molecular Residual Disease (MRD). By combining personalised tumour-informed detection and broad tumour-agnostic profiling, it helps your doctor monitor your health, detect relapse early, and tailor treatment to your unique needs. This test provides ongoing insights to ensure better outcomes and timely care.

KNOW MORE

Cancertrack™ and Target-MRD™ empower you and your care team with critical tools to stay ahead of cancer and make timely, informed decisions for better management.

cancer-screening

Monitoring